← All trials
NCT00810810
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2006
- Primary completion
- Aug 1, 2010
- Completion date
- Aug 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 287
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of WashingtonLead sponsor
- University of WashingtonOverall official - principal investigator
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- University of WashingtonReponsible party - principal investigator
- Puget Sound Blood CenterOverall official - principal investigator
- Puget Sound Blood CenterCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.